Europa · Agencias y tiempo real · Reuters Technology

Danaher says it has 'building blocks' for AI drug discovery growth

Publicado por Reuters Technology · Reino Unido hace 13 h

Life sciences firm Danaher is well positioned to ‌benefit as drugmakers increasingly adopt artificial intelligence to develop new medicines, its chief executive said on Wednesday,…

Leer el artículo completo en Reuters Technology Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

Danaher says it has 'building blocks' for AI drug discovery growth

También te puede interesar

Conflict in Ukraine now closer to ending than ever before, Trump says

Türkiye's BIST 100 index down at midweek close

Trump's MAGA Inc unleashes $277 million last-ditch effort to save Republicans in key US races

Gold edges higher as yields retreat, Fed decision in focus

EU leaders to discuss 2027 money for Ukraine, next EU budget on November 26-27

Europe risks startup exodus as regulation, funding and skill gaps hamper AI adoption, AWS EMEA head says

Danaher says it has 'building blocks' for AI drug discovery growth

Compartir

También te puede interesar

Conflict in Ukraine now closer to ending than ever before, Trump says

Türkiye's BIST 100 index down at midweek close

Trump's MAGA Inc unleashes $277 million last-ditch effort to save Republicans in key US races

Gold edges higher as yields retreat, Fed decision in focus

EU leaders to discuss 2027 money for Ukraine, next EU budget on November 26-27

Europe risks startup exodus as regulation, funding and skill gaps hamper AI adoption, AWS EMEA head says